Evangelos Prokakis

7PUBLICATIONS
15CO-AUTHORS
Cancer cell biologyMolecular targetsCancer diagnosisPredictive and prognostic markersClinical midwifery
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 28, 2023
RNF40 epigenetically modulates glycolysis to support the aggressiveness of basal-like breast cancer.

Evangelos Prokakis, Shaishavi Jansari, Angela Boshnakovska

|Jan 13, 2023
Basal-like mammary carcinomas stimulate cancer stem cell properties through AXL-signaling to induce chemotherapy resistance.

Garyfallia Pantelaiou-Prokaki, Oliver Reinhardt, Nadine S Georges

|Sep 03, 2022
ROBO3s: a novel ROBO3 short isoform promoting breast cancer aggressiveness.

Marcel Werner, Anna Dyas, Iwan Parfentev

|Nov 30, 2021
Decreased PRC2 activity supports the survival of basal-like breast cancer cells to cytotoxic treatments.

Iga K Mieczkowska, Garyfallia Pantelaiou-Prokaki, Evangelos Prokakis

|May 19, 2021
USP22 promotes HER2-driven mammary carcinoma aggressiveness by suppressing the unfolded protein response.

Evangelos Prokakis, Anna Dyas, Regina Grün

|Mar 04, 2021
Bromodomain protein BRDT directs ΔNp63 function and super-enhancer activity in a subset of esophageal squamous cell carcinomas.

Xin Wang, Ana P Kutschat, Moyuru Yamada

Pageof 2

Frequent Collaborators

6 joint publications

Florian Wegwitz

4 joint publications

Steven A Johnsen

3 joint publications

Klaus Pantel

3 joint publications

Harriet Wikman